A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
Study sponsor: Prokidney
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12Actual
Enrollment · participants83Actual
Source updated2025-08-24Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.